| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |